Rosb.Ns
ROSB.NS is a specialty chemicals company that produces and sells chemical products, primarily generating revenue through the sale of these products to industrial and commercial customers.
Business. ROSB.NS is a specialty chemicals company that produces and sells chemical products, primarily generating revenue through the sale of these products to industrial and commercial customers.
Analyst recommendations
5 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
ROSB.NS is a specialty chemicals company that produces and sells chemical products, primarily generating revenue through the sale of these products to industrial and commercial customers.
ROSB.NS has a liquidity position that is characterized by a current ratio of 1.58, indicating that the company has sufficient current assets to cover its current liabilities. However, the company's free cash flow is negative at -391.03 million INR, and capital expenditures are substantial at -2.65 billion INR, suggesting a high reinvestment rate in its operations. The company's cash and equivalents amount to 922.14 million INR, which is less than its long-term debt of 4.36 billion INR, indicating a net cash outflow after accounting for total debt.
In terms of profitability, ROSB.NS has a return on equity (ROE) of 11.19% and a return on assets (ROA) of 6.52%, which are key metrics for evaluating the efficiency of equity and asset utilization. The company's gross profit of 7.28 billion INR and operating income of 2.07 billion INR reflect its ability to generate profit from its core operations. The debt-to-equity ratio of 0.33 suggests a relatively conservative capital structure, with a lower proportion of debt compared to equity.
ROSB.NS operates in a single business segment, and its revenue is primarily concentrated in one geographic region. The company's revenue of 23.96 billion INR is derived from the sale of chemical products, with no significant diversification across segments or regions. This concentration may expose the company to regional economic fluctuations and market-specific risks.
The company's growth trajectory is influenced by its capital expenditures and operating cash flow. With a capital expenditure of -2.65 billion INR and an operating cash flow of 650.68 million INR, the company is investing heavily in its operations, which may support future growth. However, the negative free cash flow indicates that the company is not generating enough cash to cover its capital expenditures, which could impact its ability to sustain growth without external financing.
ROSB.NS faces a medium liquidity risk, as indicated by its current ratio and negative free cash flow. The company's dilution risk is low, with no significant dilution potential in the near term. The company's risk assessment highlights the key flag of net cash being negative after subtracting total debt, which could affect its financial flexibility.
Recent events and disclosures related to ROSB.NS include analyst estimates and price targets. The mean price target is 601.75 INR, with a median of 600.00 INR, and the high and low price targets are 637.00 INR and 570.00 INR, respectively. The mean recommendation from analysts is 1.80, indicating a generally positive outlook, with 2 strong-buy, 2 buy, and 1 hold ratings.
- ROSB.NS has a conservative capital structure with a debt-to-equity ratio of 0.33.
- The company's return on equity of 11.19% and return on assets of 6.52% indicate strong profitability.
- ROSB.NS is heavily invested in capital expenditures, with a significant outflow of -2.65 billion INR.
- The company's liquidity position is medium, with a current ratio of 1.58 but a negative free cash flow.
- Analysts have a generally positive outlook on ROSB.NS, with a mean recommendation of 1.80 and a mean price target of 601.75 INR.
- The company's revenue is concentrated in a single segment and geographic region, which may increase its exposure to market-specific risks.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 28,50 |
| Revenue | —no estimate | —no estimate | 26,6B INR |
| Operating income | —no estimate | —no estimate | 2,4B INR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- ROSB.NS Market data — financials · 2026-05-29
- Rossari Biotech Ltd Market data — analyst estimates · 2026-05-29